GenIbet GMP manufacturing units focus on process robustness and consistency to ensure product quality, purity and efficacy. Our multi-products manufacturing facilities feature state-of-the-art equipment for l, animal cells derived viral and microbial products for clinical trials phase I-II in accordance with cGMP guidelines.
GenIbet GenIbet facility is routinely inspected by the local Portuguese Regulatory Authority – Infarmed – since 2009 and holds a Manufacturing Authorization for biopharmaceuticals production and manufacture of Investigational Medicinal Products (IMPs). Moreover, over the last 10 years GenIbet has hold more than 30 audits, including Astra Zeneca, Alexion, PPD, Merck, GSK and Novartis, without any critical observations.
GenIbet is approved for the manufacture of:
Required Cookies The cookies allow to customize the commercial offers that are presented to you, considering your interests. They can be our own or third party cookies. Please, be advised that, even if you do not accept these cookies, you will receive commercial offers, but do not match your preferences.
Functional Cookies The cookies offer you a more complete and personalised experience, allowing to safe preferences, showing you relevant content to your liking and send you alerts you have requested.
Advertising Cookies These cookies offer the possibility to connect to social media and share content from our website.